These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14626188)

  • 41. [Effect of Composite Salviae Dropping Pill on function of platelet activation in patients with unstable angina pectoris].
    Jin L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Jun; 20(6):415-7. PubMed ID: 11789221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The clinical observation of puerarin injection on unstable angina pectoris].
    Chen X
    Zhong Yao Cai; 2004 Jan; 27(1):77-8. PubMed ID: 15179793
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Multi-centered, randomized controlled clinical study on Chinese medicine formula particles for hyperlipidaemia associated with highly active antiretroviral therapy].
    Ni L; Wang RB; Guo HJ; Tan XH; Sun LJ; Zheng YH; Duan CY; Hu DQ; Wang WJ; Wang YG; Zhao HX
    Zhongguo Zhong Yao Za Zhi; 2013 Aug; 38(15):2443-7. PubMed ID: 24228532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of ethanol extract from Matbuhi Aftimun on blood lipide level in rat hyperilpldemla model].
    Islam R; Mamat Y; Rapkat H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jul; 30(7):726-8. PubMed ID: 20929132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential protective effect of long-term therapy with Xuezhikang on left ventricular diastolic function in patients with essential hypertension.
    Ye P; Wu CE; Sheng L; Li H
    J Altern Complement Med; 2009 Jul; 15(7):719-25. PubMed ID: 19552598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of tongxinluo capsule on function of vascular endothelium in patients with unstable angina pectoris].
    Wang HJ; Huang YW; Sun J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Aug; 23(8):587-9. PubMed ID: 14503056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Levels of C-reactive protein and antibodies against oxidized low-density lipoprotein in patients with different types of coronary heart disease].
    Ma LQ; Zheng H; Wu SZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):1068-70. PubMed ID: 17666352
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Changes in serum lipids, plasma fibrinogen and other haemostatic parameters induced by ciprofibrate action in hyperlipidemic patients with and without coronary artery disease].
    Espinosa RA; Rodríguez-Roa E; Nagy E; Mijares ME; Rodríguez-Larralde A; Gil A; Lundberg U; Carvajal Z; Castillo L; Arocha-Piñango CL
    Invest Clin; 2006 Mar; 47(1):35-48. PubMed ID: 16562643
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of xuezhikang on the treatment of primary hyperlipidemia].
    Kou W; Lu Z; Guo J
    Zhonghua Nei Ke Za Zhi; 1997 Aug; 36(8):529-31. PubMed ID: 10436958
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of the lipid lowering ability, anti-inflammatory effects and clinical safety of intensive therapy with Zhibitai, a Chinese traditional medicine.
    Xu DY; Shu J; Huang QY; Wasti B; Chen C; Liu L; Zhao SP
    Atherosclerosis; 2010 Jul; 211(1):237-41. PubMed ID: 20189174
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rovamycine as add-on treatment in unstable angina and 4 year evolution with major cardiovascular events.
    Rădoi M; Bobescu E; Agache I
    Rom J Intern Med; 2003; 41(3):237-46. PubMed ID: 15526507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy.
    Puri R; Nissen SE; Libby P; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
    Circulation; 2013 Nov; 128(22):2395-403. PubMed ID: 24043299
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Soy consumption and phytoestrogens: effect on serum prostate specific antigen when blood lipids and oxidized low-density lipoprotein are reduced in hyperlipidemic men.
    Jenkins DJ; Kendall CW; D'Costa MA; Jackson CJ; Vidgen E; Singer W; Silverman JA; Koumbridis G; Honey J; Rao AV; Fleshner N; Klotz L
    J Urol; 2003 Feb; 169(2):507-11. PubMed ID: 12544298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced plasma levels of oxidized low-density lipoprotein increase circulating nuclear factor-kappa B activation in patients with unstable angina.
    Cominacini L; Anselmi M; Garbin U; Fratta Pasini A; Stranieri C; Fusaro M; Nava C; Agostoni P; Keta D; Zardini P; Sawamura T; Lo Cascio V
    J Am Coll Cardiol; 2005 Sep; 46(5):799-806. PubMed ID: 16139128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Jinshuibao capsule combined losartan potassium intervened early renal damage of hypertension patients of yin and yang deficiency: a clinical research].
    Zhang CQ; Yin JQ; Xin Q; Wang YQ; Ge ZM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):731-5. PubMed ID: 23980348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Heparin-induced extacorporeal low-density lipoprotein-lipoprotein alpha-fibrinogen precipitation in 36 cases].
    Mo JK; Li YX; Lei D; Wu DH
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar; 22(3):278-9. PubMed ID: 12390791
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of cytoprotectors on lipid metabolism and C-reactive protein in patients with coronary heart disease].
    Zaremba IeKh; Karpliak VM
    Lik Sprava; 2012; (7):97-100. PubMed ID: 23350124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Danshen injection as adjuvant treatment for unstable angina pectoris: A systematic review and meta-analysis.
    Wu JR; Liu S; Zhang XM; Zhang B
    Chin J Integr Med; 2017 Apr; 23(4):306-311. PubMed ID: 27921196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of tongxinluo capsule on plasma endothelin and calcitonin gene related peptide in patients with unstable angina pectoris].
    Liang TJ; Zhang CQ; Zhang W
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 Jun; 22(6):435-6. PubMed ID: 12585189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel findings in relation to multiple anti-atherosclerotic effects of XueZhiKang in humans.
    Xu RX; Zhang Y; Guo YL; Ma CY; Yao YH; Li S; Li XL; Qing P; Gao Y; Wu NQ; Zhu CG; Liu G; Dong Q; Sun J; Li JJ
    Chronic Dis Transl Med; 2018 Jun; 4(2):117-126. PubMed ID: 29988855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.